 Sure. When the FDA updated its Mifepristone regulations in 2016, it did so based on more than 70 high-quality clinical studies, as well as real-world data from millions of patients both within the United States and around the world. It gave a thoughtful explanation that aligned with the uniform recommendations of the nation's leading medical authorities.